questionText: To ask the Secretary of State for Health and Social Care, what estimate he has made of the average travel distance for patients accessing SABR treatment for prostate cancer.
answerText: The clinical commissioning policy for stereotactic ablative radiotherapy (SABR) for localised prostate cancer was supported by an Equality and Health Inequalities Impact Assessment. This identified several potential benefits for patients, including fewer ...
heading: Prostate Cancer: Radiotherapy